Latest filing published 28 Feb 2025 for Artiva Biotherapeutics, Inc..
Insider track record
No signal scores available.
Thorsten Graef: trading record in brief
Filings by Thorsten Graef span 2 companies, the busiest being Artiva Biotherapeutics, Inc. and Pharmacyclics Inc. We count 3 filings; the first trade dates from 31 October 2013 and the latest from 26 February 2025.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 28 February 2025 came the latest disclosure, a share grant in Artiva Biotherapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Thorsten Graef
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 60,000 shares0Common StockSEC:0001415889-25-006036:0
- 20,000 shares0Common StockSEC:0001415889-24-023363:0
- 143 shares@ US$52.24Common StockSEC:0001209191-13-050950:0
3 of 3 declarations
